Ami Drugs And Speciality Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 11-12-2024
- Paid Up Capital ₹ 1.50 M
as on 11-12-2024
- Company Age 21 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.45 Cr
as on 11-12-2024
- Revenue -93.92%
(FY 2021)
- Profit -98.01%
(FY 2021)
- Ebitda 90.08%
(FY 2021)
- Net Worth 1.62%
(FY 2021)
- Total Assets -29.38%
(FY 2021)
About Ami Drugs And Speciality Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.50 M.
The company has closed loans amounting to ₹1.45 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kiranben Chovatia, Girishkumar Chovatia, and Ameeshi Chovatia serve as directors at the Company.
- CIN/LLPIN
U24231GJ2003PTC041913
- Company No.
041913
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jan 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ami Drugs And Speciality Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girishkumar Chovatia  | Director | 28-Jan-2003 | Current |
| Kiranben Chovatia | Director | 28-Jan-2003 | Current |
| Ameeshi Chovatia | Director | 12-Jul-2017 | Current |
Financial of Ami Drugs And Speciality Chemicals.
Ami Drugs And Speciality Chemicals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 93.92% decrease. The company also saw a substantial fall in profitability, with a 98.01% decrease in profit. The company's net worth moved up by a moderate rise of 1.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ami Drugs And Speciality Chemicals?
In 2021, Ami Drugs And Speciality Chemicals had a promoter holding of 47.13% and a public holding of 52.87%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ami Bio Tech Private LimitedActive 13 years 10 monthsKiranben Chovatia and Ameeshi Chovatia are mutual person
Ami Lifesciences Pvt LtdActive 30 years 9 monthsKiranben Chovatia, Girishkumar Chovatia and 1 more are mutual person
Deltagene Biosciences Private LimitedActive 1 year 11 monthsKiranben Chovatia and Girishkumar Chovatia are mutual person
- Adc Finserv Private LimitedActive 4 years 4 months
Kiranben Chovatia and Ameeshi Chovatia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Uti Bank Ltd Creation Date: 30 Mar 2007 | ₹8.00 M | Satisfied |
State Bank Of Saurashtra Creation Date: 28 Apr 2005 | ₹6.50 M | Satisfied |
How Many Employees Work at Ami Drugs And Speciality Chemicals?
Unlock and access historical data on people associated with Ami Drugs And Speciality Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ami Drugs And Speciality Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ami Drugs And Speciality Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
